Skip to main content

Lynparza 50Mg: Progressed ovarian malignancy (monotherapy) Shown as first-line upkeep treatment for pernicious or suspected harmful substantial or germline BRCA-changed (gBRCAm) progressed ovarian disease in patients who are in finished or halfway reaction to first-line platinum-based chemotherapy.
https://yourmedikart.com/product/lynparza-50-mg/

wickedeye, Aug 25 2020 on masssly.goifnetwork.org